Results 91 to 100 of about 13,679 (137)

Bortezomib-melphalan-prednisone <I>versus</i> lenalidomide-dexamethasone in elderly patients with multiple myeloma: the Real MM phase IV trial. [PDF]

Haematologica
Bringhen S, Cani L, Giuliani N, Mangiacavalli S, Benevolo G, Antonioli E, Zambello R, Ria R, Vincelli ID, Ronconi S, More S, Falcone AP, Allegra A, D'Agostino M, Evangelista A, Capra A, Sciorsci E, Curci P, Tosi P, Liberati AM, Cafro AM, Belotti A, Patriarca F, Mannina D, Mancuso K, Cattel F, Ciccone G, Bruno B, Boccadoro M, Larocca A.   +29 more
europepmc   +1 more source

Safety of Rapid Daratumumab Infusion: A Retrospective, Multicenter, Real-Life Analysis on 134 Patients With Multiple Myeloma. [PDF]

Front Oncol, 2022
Bonello F, Rocchi S, Barilà G, Sandrone M, Talarico M, Zamagni E, Scaldaferri M, Vedovato S, Bertiond C, Pavan L, Bringhen S, Cattel F, Zambello R, Cavo M, Mina R.   +14 more
europepmc   +1 more source

M-protein-related necrobiotic granuloma in a multiple myeloma patient treated with daratumumab, lenalidomide and dexamethasone. [PDF]

Br J Haematol
Bertuglia G, Bringhen S, Bruno B, Impalà GA, D'Agostino M.   +4 more
europepmc   +1 more source

The Emerging Role of Left Atrial Strain in Cardiovascular Risk Stratification for Multiple Myeloma Patients Undergoing Carfilzomib Therapy. [PDF]

Cancers (Basel)
Colomba A, Airale L, Lasagno A, Mingrone G, Astarita A, Vallelonga F, Leone D, Sanapo M, Paladino A, Novello F, Bringhen S, Gay F, Veglio F, Milan A.   +13 more
europepmc   +1 more source

Mismatch Between Preclinical Cardio-Oncology and Clinical Oncology Research. [PDF]

JACC CardioOncol
Cagnazzo R, Stabile M, Zoppoli G, De Boer RA, Meijers WC, van Der Meer P, Ameri P.   +6 more
europepmc   +1 more source

Liposomal daunorubicin and dexamethasone as a treatment for multiple myeloma--the DD Protocol. [PDF]

Sao Paulo Med J, 2005
Dulley FL, Saboya R, Hungria VT, Bueno ND, Mello FG, Frota MT, Chiattone CS, Barros JC, Mori NS, Sturaro D, Macedo MC, Silva RL, Melo LM, Souza CA.   +13 more
europepmc   +1 more source

Haemodynamic Forces: Emerging Markers of Ventricular Remodelling in Multiple Myeloma Cardiovascular Baseline Risk Assessment. [PDF]

Cancers (Basel)
Colomba A, Astarita A, Mingrone G, Airale L, Catarinella C, Vallelonga F, Leone D, Cesareo M, Paladino A, Bringhen S, Gay F, Pedrizzetti G, Veglio F, Milan A.   +13 more
europepmc   +1 more source